Almirall, S.A.: all 74 studies
Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic DermatitisNot yet recruitingNCT07873801Phase 3
- A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis SuppurativaRecruitingNCT07547813Phase 2
- A Study of Lebrikizumab in Adults With Nummular EczemaRecruitingNCT07542483Phase 3
- A Study of LAD106 in Healthy Adult ParticipantsRecruitingNCT07471932Phase 1
- A Study of LAD603 in Adults With Alopecia AreataRecruitingNCT07311564Phase 2
- A Study of LAD191 in Adults With Hidradenitis SuppurativaRecruitingNCT07151937Phase 2
- A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants with Moderate-to-Severe Atopic DermatitisRecruitingNCT06815380
- A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque PsoriasisRecruitingNCT06030076
- A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)RecruitingNCT06029257
- A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic KeratosisCompletedNCT06135415Phase 3Results posted
- Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic DermatitisCompletedNCT05990725Phase 3Results posted
- A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in AdultsCompletedNCT05811234Results posted
- A Study of Tirbanibulin on the Wellbeing of Participants With Actinic KeratosesCompletedNCT05741294Phase 4Results posted
- A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic KeratosisCompletedNCT05279131Phase 3Results posted
- Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic KeratosisCompletedNCT05260073Results posted
- A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for CyclosporineCompletedNCT05149313Phase 3Results posted
- Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)CompletedNCT04820673Results posted
- Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical PracticeCompletedNCT04203693Results posted
- A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)CompletedNCT03285490Phase 3Results posted
- A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or ScalpCompletedNCT03285477Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic AlopeciaCompletedNCT03004469Phase 3Results posted
- Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne VulgarisCompletedNCT02959970Phase 4Results posted
- Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or ScalpCompletedNCT02838628Phase 2Results posted
- A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne VulgarisCompletedNCT02413346Phase 3Results posted
- Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of AcneCompletedNCT02322866Phase 3Results posted
- Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of AcneCompletedNCT02320149Phase 3Results posted
- Safety and Efficacy Study of Dapsone Gel in Patients With Acne VulgarisCompletedNCT01974323Phase 3Results posted
- A Safety and Efficacy Study of Dapsone Gel in Patients With Acne VulgarisCompletedNCT01974141Phase 3Results posted
- Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne VulgarisCompletedNCT01628549Phase 2Results posted
- Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed PatientsCompletedNCT01385696Phase 3Results posted
- A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic DermatitisActive, not recruitingNCT06526182Phase 3
- Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune DiseaseCompletedNCT06488209Phase 1
- A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live SettingActive, not recruitingNCT06488170
- A Single and Multiple Ascending Dose Study of LAD603 in Healthy SubjectsCompletedNCT06200597Phase 1
- Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic DermatitisCompletedNCT05916365Phase 3
- UV Sensor in Patients With Actinic KeratosisCompletedNCT05481073
- A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or ScalpActive, not recruitingNCT05387525Phase 4
- Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE StudyCompletedNCT04823247
- Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque PsoriasisTerminatedNCT04339595Phase 4
- Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI)CompletedNCT04322669Phase 4
- Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate TherapyCompletedNCT04263610Phase 4
- Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)CompletedNCT04229836Phase 4
- Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of OnychomycosisWithdrawnNCT03094468Phase 3
- Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/sWithdrawnNCT03079973Phase 3
- Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008CompletedNCT02955693Phase 1
- Photosensitization Study in Androgenetic AlopeciaCompletedNCT02791243Phase 1
- Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by PsoriasisCompletedNCT02606760Phase 3
- Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail OnychomycosisCompletedNCT02549001Phase 3
- Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric PopulationCompletedNCT02547701Phase 3
- Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic KeratosesCompletedNCT02289768Phase 3
- Efficacy and Safety of Tazarotene Gel in Nail PsoriasisCompletedNCT02235480Phase 2
- A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate PsoriasisCompletedNCT02180464Phase 2
- Dermal Tolerability of Dapsone Gel in Healthy VolunteersCompletedNCT02117752Phase 1
- Photoallergy Potential of Dapsone Gel in Healthy VolunteersCompletedNCT02117739Phase 1
- Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque TestCompletedNCT02111499Phase 1/2
- Phototoxicity Test of Dapsone Gel in Healthy VolunteersCompletedNCT02108483Phase 1
- A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and CorticosteroidCompletedNCT02094274Phase 1
- Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPDCompletedNCT01915784Phase 3
- LAS41008 in Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01726933Phase 3
- Neurophysiological Study of Sativex in Multiple Sclerosis (MS) SpasticityCompletedNCT01538225Phase 3
- Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque TestCompletedNCT01462643Phase 2
- Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque TestCompletedNCT01360944Phase 2
- LAS41005 in Hyperkeratotic Actinic KeratosisCompletedNCT01358851Phase 2
- Clinical Trial to Investigate Efficacy of LAS41004 in PsoriasisCompletedNCT01283698Phase 2
- Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic KeratosisCompletedNCT01265602Phase 3
- Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of PsoriasisCompletedNCT01119339Phase 2
- Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic EczemaCompletedNCT01119313Phase 2
- Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida InfectionsCompletedNCT01102387Phase 2
- Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea PedisCompletedNCT01096472Phase 2
- Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected EczemaCompletedNCT01020994Phase 2
- Efficacy and Safety Study of LAS41007 in the Treatment of Actinic KeratosisCompletedNCT00991861Phase 2
- Study on the Efficacy of LAS41005 in the Treatment of Actinic KeratosisCompletedNCT00987246Phase 3
- Standardized sTudy With Almotriptan in eaRly Treatment of MigraineCompletedNCT00725140
- ARTIST: ARThrose Intervention STandardiséeCompletedNCT00462319Phase 4